HYEX — Healthy Extracts Balance Sheet
0.000.00%
- $42.22m
- $42.79m
- $3.11m
Annual balance sheet for Healthy Extracts, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.059 | 0.222 | 0.066 | 0.019 | 0.112 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.013 | 0.133 | 0.106 | 0.03 | 0.011 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.49 | 2.31 | 2.04 | 1.9 | 1.66 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.006 | 0.001 | 0.005 | 0.003 | 0.003 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 3.12 | 3.03 | 2.78 | 2.64 | 2.38 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.262 | 0.559 | 0.903 | 1.67 | 1.97 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.262 | 0.559 | 0.903 | 1.68 | 1.97 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 2.85 | 2.47 | 1.88 | 0.955 | 0.41 |
| Total Liabilities & Shareholders' Equity | 3.12 | 3.03 | 2.78 | 2.64 | 2.38 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |